Anteris Technologies Global Corp.
Description
Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.
About
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 4 | — | 4 |
| Average estimate | — | -0.44 | — | -1.73 |
| Low estimate | — | -0.50 | — | -2.03 |
| High estimate | — | -0.30 | — | -1.30 |
| Last year EPS | — | — | — | -2.92 |
Growth estimates
Income statement
| 2023 | |
|---|---|
| Fiscal date | 2023-12-31 |
| Total reported revenue | 2.73M |
| Cost of revenue | 1.86M |
| Gross profit | 876,800 |
| Operating expense | |
| Research & development | 31.02M |
| Selling general and admin | 17.05M |
| Other operating expenses | -717,331 |
| Operating income | -46.79M |
| Non operating interest income | |
| Income | 428,059 |
| Expense | 67,089 |
| Other income expense | -336,259 |
| Pretax income | -46.76M |
| Tax provision | — |
| Net income | -46.76M |
| Basic EPS | -1.28 |
| Diluted EPS | -1.28 |
| Basic average shares | 35.94M |
| Diluted average shares | 35.94M |
| EBITDA | -44.41M |
| Net income from continuing op. | -46.76M |
| Minority interests | 741,556 |
| Preferred stock dividends | — |
Balance sheet
| 2023 | |
|---|---|
| Fiscal date | 2023-12-31 |
| Total assets | 30.53M |
| Current assets | |
| Cash | 13.01M |
| Cash equivalents | 8.01M |
| Cash and cash equivalents | 21.03M |
| Other short term investments | — |
| Accounts receivable | 407,556 |
| Other receivables | 723,883 |
| Inventory | 442,348 |
| Prepaid assets | 845,129 |
| Restricted cash | 61,656 |
| Assets held for sale | — |
| Hedging assets | — |
| Other current assets | — |
| Non current assets | |
| Properties | 1.49M |
| Land and improvements | — |
| Machinery furniture equipment | 7.08M |
| Construction in progress | 492,273 |
| Leases | — |
| Accumulated depreciation | -3.58M |
| Goodwill | 410,146 |
| Investment properties | — |
| Financial assets | — |
| Intangible assets | 410,146 |
| Investments and advances | — |
| Other non current assets | 417,269 |
| Total liabilities | 11.63M |
| Current liabilities | |
| Accounts payable | 3.14M |
| Accrued expenses | 3.87M |
| Short term debt | 668,921 |
| Deferred revenue | — |
| Tax payable | — |
| Pensions | 850,867 |
| Other current liabilities | 922,683 |
| Non current liabilities | |
| Long term debt | 926,776 |
| Provision for risks and charges | — |
| Deferred liabilities | — |
| Derivative product liabilities | — |
| Other non current liabilities | 93,841 |
| Shareholders equity | |
| Common stock | 217.33M |
| Retained earnings | -200.10M |
| Other shareholders equity | -9.56M |
| Total shareholders equity | 18.90M |
| Additional paid in capital | 11.63M |
| Treasury stock | — |
| Minority interest | -402,835 |
Cash flow statement
| 2023 | |
|---|---|
| Operating Activities | |
| Net Income | -46.76M |
| Depreciation | 1.16M |
| Deferred Taxes | — |
| Stock-Based Compensation | 5.76M |
| Other Non-Cash Items | 101,856 |
| Accounts Receivable | -345,011 |
| Accounts Payable | — |
| Other Assets & Liabilities | -86,725 |
| Operating Cash Flow | -40.18M |
| Investing Activities | |
| Capital Expenditures | -2.36M |
| Net Intangibles | -6,644 |
| Net Acquisitions | -213,000 |
| Purchase of Investments | — |
| Sale of Investments | — |
| Investing Cash Flow | -2.58M |
| Financing Activities | |
| Long-Term Debt Issuance | — |
| Long-Term Debt Payments | -808,049 |
| Other Financing Charges | -2.68M |
| Financing Cash Flow | 49.34M |
| Other Cash Details | |
| End Cash Position | 21.09M |
| Income Tax Paid | — |
| Interest Paid | 38,473 |
| Free Cash Flow | -37.03M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|
